Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAIL-OUT
ISRCTN98978563Phase 4Completed
- Sponsor
- University Hospitals of Leicester NHS Trust
- Start
- Nov 2006
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
01
Overview
Phase 4, randomised, open-label trial in coronary arteriosclerosis comparing Provisional bivalirudin after heparin with Provisional abciximab after heparin (2 arms). Primary endpoint: Major and minor bleeding complication rate. Started Nov 2006; status: completed.
02
Drugs
bivalirudinabciximabheparin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ISRCTN98978563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN98978563.